CN101011511A - Externally applied medicament for treating soft tissue injury - Google Patents

Externally applied medicament for treating soft tissue injury Download PDF

Info

Publication number
CN101011511A
CN101011511A CN 200710061416 CN200710061416A CN101011511A CN 101011511 A CN101011511 A CN 101011511A CN 200710061416 CN200710061416 CN 200710061416 CN 200710061416 A CN200710061416 A CN 200710061416A CN 101011511 A CN101011511 A CN 101011511A
Authority
CN
China
Prior art keywords
soft tissue
tissue injury
radix
externally applied
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200710061416
Other languages
Chinese (zh)
Inventor
王振宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200710061416 priority Critical patent/CN101011511A/en
Publication of CN101011511A publication Critical patent/CN101011511A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an externally-used medicinal composition for treating soft tissue injury, wherein the raw materials of the effective constituents comprise (by weight ratio) Sichuan aconite root 8-12, safflower 8-10, arisaema tuber 7-11, Rhododendron molle 8-12, Clematis chinensis 7-11, rhizome of Sichuan lovage 8-12, tetrandra root 7-11, corydalis tuber 8-12, Tripterygium wilfordii 7-11, peach kernel 7-11 and borneol 0.4-0.5.

Description

A kind of medicine for external use for the treatment of soft tissue injury
Technical field
The present invention relates to a kind of medicine for external use for the treatment of soft tissue injury.
Technical background
Soft tissue is meant tissues such as skin, subcutaneous tissue, muscle, tendon, fascia, joint capsule, ligament.Soft tissue is because of effect that is subjected to extraneous some direct or indirect violence factor or the damage of straining for a long time and causing, claim soft tissue injury (muscle and tendon injury), soft tissue injury is the illness of seeing at most in the orthopaedics, sickness rate is higher in daily production and life, all can there be the pain performance in soft tissue injury initial stage and later stage, the wound hematoma or the inflammatory reaction at initial stage, the muscle insertion in later stage, periosteum, fascia, tendon, muscle etc. are fibrosis or cicatrixization gradually, the neural blood vessel irriate suffers oppression, local metabolic changes all can stimulate local nerve pain, the medicine for external use safflower oil that is used for the treatment of soft tissue injury at present, externally applied liniment such as bone-setting liquor treatment time is long, and medical expense height, therapeutic effect are not very good.
Summary of the invention
Technical problem to be solved by this invention provides the medicine for external use of the treatment soft tissue injury that a kind of treatment time is short, medical expense is low, therapeutic effect is good.
The present invention adopts following technical scheme:
Raw material and weight proportion that the present invention makes active ingredient are: Radix Aconiti 8-12, Flos Carthami 8-10, Rhizoma Arisaematis 7-11, Flos Rhododendri Mollis 8-12, Radix Clematidis 7-11, Rhizoma Chuanxiong 8-12, Radix Stephaniae Tetrandrae 7-11, Rhizoma Corydalis 8-12, Radix Tripterygii Wilfordii 7-11, Semen Persicae 7-11, Borneolum Syntheticum 0.4-0.5.
Good effect of the present invention is as follows: the pharmacological action of medicine of the present invention: Radix Aconiti: the effect of expelling wind and cold is arranged, be used for arthralgia due to cold-dampnes, trusted subordinate's cold type of pain, wind syndrome of head pain, migraine, traumatic injury pain etc.; Flos Carthami: the merit of blood circulation promoting and blood stasis dispelling is excellent; Rhizoma Arisaematis: external application energy mass dissipating and swelling eliminating pain relieving; Flos Rhododendri Mollis: cold sedation-analgesia dispels the wind; Radix Clematidis: property is apt to away the energy the meridian dredging, the wind-damp dispelling analgesic effect is stronger; Rhizoma Chuanxiong: energy blood-activating and qi-promoting, wind-expelling pain-stopping; Radix Stephaniae Tetrandrae: kind energy wind-damp dispelling pain relieving; Rhizoma Corydalis: grasp the hot logical property of temperature of loosing, and can invigorate blood circulation and can circulation of qi promoting, have good pain relieving effect; Radix Tripterygii Wilfordii: tool inflammation-diminishing function; Semen Persicae: the blood circulation promoting and blood stasis dispelling effect is stronger; Borneolum Syntheticum: external has clearing away heat to alleviate pain, anticorrosion itching-relieving efficacies.
More than the common compatibility of each medicine, play the merit of blood-activating and qi-promoting expelling wind and removing dampness eliminating blood stasis and smoothing collaterals clearing away heat to alleviate pain altogether.
Manufacture method: pulverizing after said medicine mixed and joining concentration behind the 80-100 mesh sieve is in 75% the ethanol, in the weight ratio of medicine and ethanol is that 1: 7 ratio was put into the container bubble after 5 days, is that 10: 1 ratio adds entry and promptly makes in medicine, water weight ratio again.
Using method: use towel hot compress or diathermy after embrocating affected part.
The traditional Chinese medical science thinks that local qi stagnation blood stasis after the wound, vim and vigour circulation are not smooth, is diagnosed according to the principle of " stagnation of QI and blood may bring about pain ".So far accepted these type of patient 456 people clinically altogether for medical treatment from 2003, how more with person between twenty and fifty, 20-45 year patient reaches 380 people, using medicine for external use of the present invention is that externally applied liniment is smeared medicine, taking a turn for the better and curing the patient has 439 people, and invalid patient has 17 people, and total effective rate reaches more than 95%.
Medicine for external use of the present invention has following advantage through clinical practice:
One, because basic Chinese crude drug of the present invention has only 11 kinds, and medicaments preparation technology is comparatively simple, so have the inexpensive advantage of cost, the patient of the general state of an illness only need treat a course of treatment (about 10 days), can reach better therapeutic effect.
Two, utilize externally applied liniment treatment soft tissue injury of the present invention, have short treating period, effective percentage height and eutherapeutic advantage.(general state of an illness patient needs about 10 days from treating to only to cure).
Three, externally applied liniment using method of the present invention is simple and convenient, and the patient only needs liniment is applied to the affected part, and uninterrupted medication gets final product.Need not be in hospital, and stop the other treatment method.
Four, all form owing to externally applied liniment of the present invention, and be external application, compare advantage with no side effects with using Western medicine by the Chinese herbal medicine compatibility.
Model case:
(1) Wang: the man, 21 years old, Li Zhuan people from village in Feixiang County was because of right lower limb was damaged 7 days, local soft tissue swelling, tenderness is obvious, and limitation of activity uses orthopaedics liniment medicine for external use of the present invention every day 3 times, swelling symptom and pain obviously alleviate after 3 days, week back healing, and patient's out-of-bed activity is freely.
(2) poplar: the man, 26 years old, river shoal, Chengan County people from village, right sprained ankle 2 months shows that through film making bony structures is normal, checks that the slight spasm of local soft tissue, tenderness, joint motion are limited, skin surface does not have scratch, goes to a doctor on October 30th, 2005.Treat with old soft tissue injury disease, advise patient to be coated with orthopaedics liniment of the present invention 5 times every day outward, and with hot towel hot compress, continuous 10 days, patient's pain relief, swelling disappears, functional rehabilitation.
(3) appoint so-and-so: the woman, 47 years old, Feixiang County Dong Zhangbao people from village, right elbow joint traumatic injury 3 days, go to a doctor in May, 2006, find fracture through film making, obvious pain, soft tissue swelling, function limitation, be coated with 3 outside with orthopaedics liniment of the present invention, take a turn for the better, swelling and pain disappear after 10 days, recovery from illness.
The specific embodiment: embodiments of the invention are as shown in the table:
Component Content (ratio of weight and number)
Radix Aconiti 8 10 12
Flos Carthami 10 12 8
Rhizoma Arisaematis 7 9 11
Flos Rhododendri Mollis 12 10 8
Radix Clematidis 9 7 11
Rhizoma Chuanxiong 10 8 12
Radix Stephaniae Tetrandrae 7 11 9
Rhizoma Corydalis 10 12 8
Radix Tripterygii Wilfordii 7 9 11
Semen Persicae 9 11 7
Borneolum Syntheticum 0.4 0.45 0.5

Claims (1)

1, a kind of treatment soft tissue injury medicine for external use is characterized in that raw material and the weight proportion of wherein making active ingredient are: Radix Aconiti 8-12, Flos Carthami 8-10, Rhizoma Arisaematis 7-11, Flos Rhododendri Mollis 8-12, Radix Clematidis 7-11, Rhizoma Chuanxiong 8-12, Radix Stephaniae Tetrandrae 7-11, Rhizoma Corydalis 8-12, Radix Tripterygii Wilfordii 7-11, Semen Persicae 7-11, Borneolum Syntheticum 0.4-0.5.
CN 200710061416 2007-01-16 2007-01-16 Externally applied medicament for treating soft tissue injury Pending CN101011511A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200710061416 CN101011511A (en) 2007-01-16 2007-01-16 Externally applied medicament for treating soft tissue injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200710061416 CN101011511A (en) 2007-01-16 2007-01-16 Externally applied medicament for treating soft tissue injury

Publications (1)

Publication Number Publication Date
CN101011511A true CN101011511A (en) 2007-08-08

Family

ID=38699350

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200710061416 Pending CN101011511A (en) 2007-01-16 2007-01-16 Externally applied medicament for treating soft tissue injury

Country Status (1)

Country Link
CN (1) CN101011511A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104138485A (en) * 2014-07-23 2014-11-12 董宝珍 External application medicinal liquor for treating traumatic injury
CN105412371A (en) * 2015-12-07 2016-03-23 吴兴玉 External medicine for treating soft tissue injury
CN109364178A (en) * 2018-12-19 2019-02-22 曲沃李时珍医药科技有限公司 A kind of cold compress gel and preparation method thereof for improving closed soft tissue inflammation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104138485A (en) * 2014-07-23 2014-11-12 董宝珍 External application medicinal liquor for treating traumatic injury
CN105412371A (en) * 2015-12-07 2016-03-23 吴兴玉 External medicine for treating soft tissue injury
CN109364178A (en) * 2018-12-19 2019-02-22 曲沃李时珍医药科技有限公司 A kind of cold compress gel and preparation method thereof for improving closed soft tissue inflammation

Similar Documents

Publication Publication Date Title
CN101214286B (en) Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases
CN101564474A (en) Foot soaking preparation for treating gout and preparation method thereof
CN102309723B (en) Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof
CN104398640A (en) Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof
CN102178817B (en) Traditional Chinese medicine composition for treating multiple lipoma
CN101011511A (en) Externally applied medicament for treating soft tissue injury
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN1478525A (en) Medicated wine for treating traumatic injury
CN101912458B (en) Medicament for treating protrasion of the lumbar intervertebral disci
CN103977113A (en) Traditional Chinese medicament for treating diabetic foot
CN103550446B (en) Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition
CN102357215A (en) Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis
CN104173689B (en) A kind of medicine for treating traumatic injury, protrusion of lumber intervertebral disc and scapulohumeral periarthritis and preparation method thereof
CN1104254C (en) Medicinal liquid for treating bone fracture
CN101288760B (en) Externally-used drug for treating appendicitis
CN103585483A (en) Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same
CN104510793A (en) Traditional Chinese medicine formula for treating arthralgia
CN102441148A (en) Plaster for treating hyperosteogeny and preparation method thereof
CN1899564B (en) External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
CN102626479B (en) External-use Chinese herbal medicine composition for chronic rheumatism treatment
CN102225125B (en) Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
CN102008527A (en) Externally applied traditional Chinese medicine powder and ventilated paster for treating haemorrhoids
CN105688096A (en) Traditional Chinese medicine composition for treating gout
CN108295218B (en) Formula of plaster for treating acute soft tissue injury
CN1404850A (en) Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070808